As we show here, CD91 expression is variable in humans, and while low CD91 expression correlates with worse prognosis in cancer, it is conceivable, though unlikely, that ectopic and excessive CD91 expression by tumor cells themselves could be immunosuppressive by acting as an HSP sink, limiting uptake by APCs. Here, HSP90B2P is linked to cancer.